Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

29 mai 2018 08h00 HE | Source: Emerald Health Therapeutics Inc.

Emerald Health Therapeutics Reports 1st Quarter 2018 Financial Results and Provides Corporate Update

VICTORIA, British Columbia, May 29, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSX-V:EMH) (OTCQX:EMHTF) (“Emerald” or “the Company”) has filed its financial statements and...
29 mai 2018 08h00 HE | Source: BioCryst Pharmaceuticals, Inc.

BioCryst Announces Presentation of Additional Analyses of the APeX-1 Clinical Trial of BCX7353 at the 2018 European Academy of Allergy and Clinical Immunology (EAACI) Congress

RESEARCH TRIANGLE PARK, N.C., May 29, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), a pharmaceutical company focused on the development and commercialization of treatments...
29 mai 2018 07h00 HE | Source: Mobiquity Technologies, Inc.

Mobiquity Networks and Advangelists Enter Into Revenue Sharing Partnership

NEW YORK, May 29, 2018 (GLOBE NEWSWIRE) -- Mobiquity Networks, a mobile location data intelligence company and a wholly owned subsidiary of Mobiquity Technologies, Inc. (OTCQB:MOBQ), today announces...
29 mai 2018 06h30 HE | Source: ChromaDex Corporation

TRU NIAGEN® to be featured at the American Society for Nutrition's Annual Meeting

IRVINE, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today that it...
24 mai 2018 12h30 HE | Source: BioCryst Pharmaceuticals, Inc.

BioCryst's BCX7353 Receives European Regulatory Designations for the Treatment of Hereditary Angioedema

EMA Grants Orphan DesignationUK MHRA Grants Promising Innovative Medicine Designation RESEARCH TRIANGLE PARK, N.C., May 24, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), a...
23 mai 2018 11h39 HE | Source: Feedvisor

Amazon Sellers See Major Opportunity in Private Label Expansion, Feedvisor Study Finds

NEW YORK, May 23, 2018 (GLOBE NEWSWIRE) -- Feedvisor, the only algo-commerce company using machine-learning and big data to help online retailers make accurate business decisions, today announced...
22 mai 2018 09h00 HE | Source: Boundless

Boundless Introduces New Lightweight, Portable, Offline Basemap Server

ST. LOUIS, May 22, 2018 (GLOBE NEWSWIRE) -- Boundless, the leader in open and scalable GIS, today introduced Boundless Offline Tile ServerTM, a lightweight, portable, purpose-built map tile server...
21 mai 2018 04h42 HE | Source: Allergy Standards Limited

Allergy Standards announces the appointment of Dr. Joey DeCourcey as Senior Scientific Officer

Dublin, Ireland, May 21, 2018 (GLOBE NEWSWIRE) -- As Senior Scientific Officer, Dr. DeCourcey will be responsible for managing ASL’s scientific standards. He will commission the development of new...
18 mai 2018 09h00 HE | Source: Kannalife Sciences, Inc.

Kannalife Sciences to be Featured in Dateline NBC Segment Covering Company’s Research on CBD-Like Molecules as Treatments for HE, CTE

NEW YORK, May 18, 2018 (GLOBE NEWSWIRE) -- Kannalife Sciences, Inc. (“Kannalife”), a bio-pharmaceutical and phyto-medical company, is excited to announce that the Company will be featured in a...
17 mai 2018 13h00 HE | Source: Nohla Therapeutics

Nohla Announces EHA Abstract Acceptance on Dilanubicel (NLA101) Off-the-Shelf Cell Therapy Showing Excellent Long-term Survival Outcomes

SEATTLE, May 17, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics, a leading developer of universal, off-the-shelf cell therapies for patients with hematologic malignances and other critical diseases,...

Page précédente

Page suivante